Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04–20
Article
Lieberman, FS, Tsien, C, Berkey, B et al. (2006). Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04–20
. JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 1510-1510. 10.1200/jco.2006.24.18_suppl.1510
Lieberman, FS, Tsien, C, Berkey, B et al. (2006). Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04–20
. JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 1510-1510. 10.1200/jco.2006.24.18_suppl.1510